12 studies found for:    Dravet Syndrome
Show Display Options
Rank Status Study
1 No longer available Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: stiripentol
2 Available Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
3 Available Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
4 Recruiting Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Verapamil
5 Not yet recruiting Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
6 Not yet recruiting A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
7 Not yet recruiting Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Clobazam
8 Not yet recruiting Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: Clobazam;   Drug: Placebo
9 Not yet recruiting A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
10 Recruiting Genetics of Severe Early Onset Epilepsies
Conditions: Epilepsy;   Epileptic Encephalopathy;   Ohtahara Syndrome;   Infantile Spasms;   Dravet Syndrome;   Malignant Migrating Partial Epilepsy of Infancy;   Early Myoclonic Epileptic Encephalopathy
Intervention:
11 Not yet recruiting An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Conditions: Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Intervention: Drug: GWP42003-P
12 Recruiting Risk Factors for Sudden Unexplained Death in Epilepsy
Condition: SUDEP
Intervention:

Indicates status has not been verified in more than two years